News|Articles|October 26, 2023
Infection Intel: Moderna, CBIC, Helocyte, Pfizer, UVDI, and CloroxPro
Staying Ahead With Company Updates and Product Innovations. This week's news is from Moderna, CBIC, Helocyte, Pfizer, UVDI, and CloroxPro.
Advertisement
Infection Intel is a new column for Infection Control Today® (ICT®) that will cover the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
Infectious Disease Doctor Discusses Hantavirus Outbreak and Public Health Preparedness, Misinformation, and Emerging Disease Threats
2
Sterile Processing Under Pressure: What Penn State Health’s Instrument Sterilization Crisis Reveals About Patient Safety Risks
3
UV-C as a Critical Second Step in Reducing HAIs: Why Adjunct Disinfection Is a Strategic Investment in High-Risk Health Care Environments
4
PASTEUR Act, NDM-CRE Surge, and the Cost of Inaction: What Infection Preventionists Need to Know About Antibiotic Policy and AMR
5